ECO Animal Health Group plc (AIM:EAH)
95.50
0.00 (0.00%)
Oct 22, 2026, 5:15 PM BST
ECO Animal Health Group Revenue
In the fiscal year ending March 31, 2026, ECO Animal Health Group had annual revenue of 87.53M GBP with 9.96% growth. ECO Animal Health Group had revenue of 48.13M in the half year ending March 31, 2026, a decrease of -6.39%. That makes ECO Animal Health Group the 21,442nd largest company in the world by revenue and 478th in the United Kingdom.
Revenue
87.53M
Revenue Growth
+9.96%
P/S Ratio
0.74
Revenue / Employee
410.92K
Employees
213
Market Cap
64.71M
Revenue by Geography
- North America (USA and Canada) 26.15M 29.9%
- China and Japan 24.06M 27.5%
- Latin America 18.81M 21.5%
- South and South East Asia 11.08M 12.7%
- Europe 4.80M 5.5%
- Rest of the World 1.43M 1.6%
- Corporate/U.K. 1.21M 1.4%
Fiscal year ended Mar 31, 2026 See the full ECO Animal Health Group breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 87.53M | 7.93M | 9.96% |
| Mar 31, 2025 | 79.60M | -9.83M | -10.99% |
| Mar 31, 2024 | 89.42M | 4.11M | 4.82% |
| Mar 31, 2023 | 85.31M | 3.12M | 3.79% |
| Mar 31, 2022 | 82.20M | -23.41M | -22.17% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Haleon | 11.15B |
| Hikma Pharmaceuticals | 2.58B |
| HUTCHMED (China) | 413.87M |
| Allergy Therapeutics | 57.29M |
| Shield Therapeutics | 44.19M |
| Provexis | 1.26M |
| Chill Brands Group | 955.18K |
ECO Animal Health Group News
- 3 months ago - ECO Animal Health Turns Profit Of £3 Mln In FY26; Receives First Order For ECOVAXXIN MS Vaccine - Nasdaq
- 10 months ago - ECO Animal Health Announces EU Marketing Authorisation For ECOVAXXIN MS - Nasdaq
- 11 months ago - ECO Animal Health Receives Positive Opinion From CVMP For ECOVAXXIN MS - Nasdaq
- 1 year ago - AIM Market Roundup: Oxford Biodynamics, GCM Resources, ECO Animal Health - The Armchair Trader